MedPath

Effects of Advance Care Planning on Patient Empowerment, Perception of Care and Healthcare Utilization in Older Patients with Multimorbidity: a Feasibility Pilot of a Randomized Controlled Trial

Conditions
zorggebruik
healthcare utilization
Patient empowerment
10001474
Registration Number
NL-OMON52742
Lead Sponsor
Department of Public Health, Section Care and Decision Making at the End of Life
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

patients >= 65 years of age with polypharmacy who gave informed consent and had
2 or more hospitalizations, day clinic admission or individual ER admissions in
the last year

Exclusion Criteria

Patients with serious cognitive impairment (MMSE score < 16), patients with a
limited life-expectancy (<6mo) and/or who are not fluent in Dutch

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Trial-feasibility is defined as the successful inclusion of 50 patients in<br /><br>total, timely administration of the intervention in 25 patients, adherence to<br /><br>follow-up procedures and identification of problems or barriers during<br /><br>recruitment, inclusion, intervention administration and follow-up. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Our main outcome for cost-effectiveness is total duration and number of<br /><br>hospital admissions, as a proxy for both costs and effects (iMCQ). In order to<br /><br>inform a possible cost-effectiveness analysis (CEA), data on health-related<br /><br>quality of life (EQ5D-5L) will also be collected. Our outcomes for patient<br /><br>assessment of care and patient empowerment are the PACIC questionnaire, the ACP<br /><br>Engagement Survey and the appointment of a surrogate decision maker and/or the<br /><br>documentation of advance directives. Other data that will be collected to<br /><br>describe our population is daily activities (ADL and iADL) and destination at<br /><br>discharge (if admitted). </p><br>
© Copyright 2025. All Rights Reserved by MedPath